771 A phase 1, first in human, open-label, dose escalation and dose expansion study of TST005 in patients with locally advanced or metastatic solid tumors | Zendy

AI Assistant Blog Pricing

771 A phase 1, first in human, open-label, dose escalation and dose expansion study of TST005 in patients with locally advanced or metastatic solid tumors

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.